349 related articles for article (PubMed ID: 29739400)
1. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis.
Behzadifar M; Gorji HA; Rezapour A; Bragazzi NL
Harm Reduct J; 2018 May; 15(1):24. PubMed ID: 29739400
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.
Salari N; Darvishi N; Hemmati M; Shohaimi S; Ghyasi Y; Hossaini F; Bazrafshan MR; Akbari H; Mohammadi M
Arch Virol; 2022 Apr; 167(4):1025-1039. PubMed ID: 35165781
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran.
Behzadifar M; Behzadifar M; Bragazzi NL
BMC Public Health; 2020 Jan; 20(1):62. PubMed ID: 31937278
[TBL] [Abstract][Full Text] [Related]
4. A Systematic and Meta-Analysis Study on the Prevalence of Tuberculosis and Relative Risk Factors for Prisoners in Iran.
Taherpour S; Bazzaz MM; Naderi H; Samarghandian S; Amirabadizadeh A; Farkhondeh T; Abedi F
Infect Disord Drug Targets; 2022; 22(1):e130921196422. PubMed ID: 34517810
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis.
Mehmandoost S; Khezri M; Mousavian G; Tavakoli F; Mehrabi F; Sharifi H; Dolan K; Shokoohi M
Public Health; 2022 Feb; 203():75-82. PubMed ID: 35032918
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis.
Behzadifar M; Gorji HA; Bragazzi NL
Arch Virol; 2018 May; 163(5):1131-1140. PubMed ID: 29411135
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
10. Current and former smokers among adolescents aged 12-17 years in Iran: a systematic review and meta-analysis.
Ehsani-Chimeh E; Sajadi HS; Behzadifar M; Aghaei M; Badrizadeh A; Behzadifar M; Bragazzi NL
BMC Public Health; 2020 Jan; 20(1):155. PubMed ID: 32005217
[TBL] [Abstract][Full Text] [Related]
11. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
12. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.
Heijnen M; Mumtaz GR; Abu-Raddad LJ
J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of exclusive breastfeeding practice in the first six months of life and its determinants in Iran: a systematic review and meta-analysis.
Behzadifar M; Saki M; Behzadifar M; Mardani M; Yari F; Ebrahimzadeh F; Majidi Mehr H; Abdi Bastami S; Bragazzi NL
BMC Pediatr; 2019 Oct; 19(1):384. PubMed ID: 31656169
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection among high-risk groups in Iran: a systematic review and meta-analysis.
Nematollahi S; Ayubi E; Almasi-Hashiani A; Mansori K; Moradi Y; Veisani Y; Jenabi E; Gholamaliei B; Khazaei S
Public Health; 2018 Aug; 161():90-98. PubMed ID: 29935474
[TBL] [Abstract][Full Text] [Related]
18. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.
Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E
An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795
[TBL] [Abstract][Full Text] [Related]
19. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus among street children in Iran.
Behzadifar M; Gorji HA; Rezapour A; Bragazzi NL
Infect Dis Poverty; 2018 Oct; 7(1):88. PubMed ID: 30269685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
